| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0007 | 1 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00072 | 1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.00067 | 1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.00062 | 1 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.00059 | 1 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.00051 | 1 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.00051 | 1 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.00034 | 1 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.00031 | 1 |